Expression and characterization of cholera toxin B -: pneumococcal surface adhesin A fusion protein in Escherichia coli:: ability of CTB-PsaA to induce humoral immune response in mice

被引:48
作者
Areas, APM
Oliveira, MLS
Miyaji, EN
Leite, LCC
Aires, KA
Dias, WO
Ho, PL [1 ]
机构
[1] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil
[2] Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil
[3] Univ Sao Paulo, Inst Biociencias, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
CTB; cholera toxin; PsaA; Streptococcus pneumoniae; nasal immunization; pneumococcus; bacterial adhesin; pneumonia; mucosa;
D O I
10.1016/j.bbrc.2004.06.118
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cholera toxin B subunit (CTB) is responsible for CT holotoxin binding to the cell and has been described as a mucosal adjuvant for vaccines. In this work, the ctxB gene was genetically fused to the psaA gene from Streptococcus pneumoniae, a surface protein involved in its colonization in the host that is also considered a vaccine antigen candidate against this pathogen. The CTB-PsaA fusion protein was expressed in Escherichia coli, and the purified protein was used for intranasal immunization experiments in Balb/C mice. CTB-PsaA was able to induce both systemic and mucosal antibodies evaluated in serum, saliva, and in nasal and bronchial wash samples, showing that CTB-PsaA is a promising molecule to be investigated as S. pneumoniae vaccine antigen candidate. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:192 / 196
页数:5
相关论文
共 19 条
[1]  
Arêas APD, 2002, PROTEIN EXPRES PURIF, V25, P481
[2]   Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate [J].
Bergquist, C ;
Lagergard, T ;
Holmgren, J .
INFECTION AND IMMUNITY, 1997, 65 (05) :1579-1583
[3]   Pneumococcal virulence factors: Structure and function [J].
Jedrzejas, MJ .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2001, 65 (02) :187-+
[4]   Inhibition of pneumococcal carriage in mice by subcutaneous immunization with peptides from the common surface protein pneumococcal surface adhesin A [J].
Johnson, SE ;
Dykes, JK ;
Jue, DL ;
Sampson, JS ;
Carlone, GM ;
Ades, EW .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (04) :489-496
[5]   Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B [J].
Kang, SM ;
Yao, Q ;
Guo, LZ ;
Compans, RW .
JOURNAL OF VIROLOGY, 2003, 77 (18) :9823-9830
[6]   Multiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant [J].
Malley, R ;
Morse, SC ;
Leite, LCC ;
Areas, APM ;
Ho, PL ;
Kubrusly, FS ;
Almeida, IC ;
Anderson, P .
INFECTION AND IMMUNITY, 2004, 72 (07) :4290-4292
[7]   The immune response to pneumococcal proteins during experimental human carriage [J].
McCool, TL ;
Cate, TR ;
Moy, G ;
Weiser, JN .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (03) :359-365
[8]  
Menezes CA, 2002, FEMS MICROBIOL LETT, V216, P67
[9]   PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae [J].
Miyaji, EN ;
Dias, WO ;
Gamberini, M ;
Gebara, VCBC ;
Schenkman, RPF ;
Wild, J ;
Riedl, P ;
Reimann, J ;
Schirmbeck, R ;
Leite, LCC .
VACCINE, 2001, 20 (5-6) :805-812
[10]   Development of a plant-derived subunit vaccine candidate against hepatitis C virus [J].
Nemchinov, LG ;
Liang, TJ ;
Rifaat, MM ;
Mazyad, HM ;
Hadidi, A ;
Keith, JM .
ARCHIVES OF VIROLOGY, 2000, 145 (12) :2557-2573